Lazard Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $728K | Buy |
|
|||||
|
2025
Q1 | $222K | Buy |
|
|||||
|
2024
Q4 | $177K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $564K | Sell |
|
|||||
|
2023
Q4 | $938K | Sell |
|
|||||
|
2023
Q3 | $1.09M | Sell |
|
|||||
|
2023
Q2 | $1.38M | Sell |
|
|||||
|
2023
Q1 | $1.81M | Buy |
|
|||||
|
2022
Q4 | $1.56M | Sell |
|
|||||
|
2022
Q3 | $2.71M | Buy |
|
|||||
|
2022
Q2 | $2.93M | Buy |
|
|||||
|
2022
Q1 | $3.29M | Sell |
|
|||||
|
2021
Q4 | $34.8M | Buy |
|
|||||
|
2021
Q3 | $39.8M | Buy |
|
|||||
|
2021
Q2 | $46.6M | Buy |
|
|||||
|
2021
Q1 | $37.7M | Buy |
|
|||||
|
2020
Q4 | $33.9M | Sell |
|
|||||
|
2020
Q3 | $36.3M | Sell |
|
|||||
|
2020
Q2 | $38.3M | Buy |
|
|||||
|
2020
Q1 | $20.7M | Buy |
|
|||||
|
2019
Q4 | $2.59M | Buy |
|